Pyrrolidine-5,5-trans-lactams. 4. Incorporation of a P3/P4 urea leads to potent intracellular inhibitors of hepatitis C virus NS3/4A protease
- PMID: 14627400
- DOI: 10.1021/ol035826v
Pyrrolidine-5,5-trans-lactams. 4. Incorporation of a P3/P4 urea leads to potent intracellular inhibitors of hepatitis C virus NS3/4A protease
Abstract
[reaction: see text] In this, the first of two Letters, we describe how a P3/P4 urea linking unit was used to greatly enhance the biochemical and replicon potency of inhibitors based upon the pyrrolidine-5,5-trans-lactam template. Compound 7b demonstrated a 100 nM IC(50) in the replicon cell-based surrogate HCV assay.
Similar articles
-
Pyrrolidine-5,5-trans-lactams. 1. Synthesis and incorporation into inhibitors of hepatitis C virus NS3/4A protease.Org Lett. 2002 Dec 12;4(25):4475-8. doi: 10.1021/ol027013x. Org Lett. 2002. PMID: 12465916
-
Pyrrolidine-5,5-trans-lactams. 5. Pharmacokinetic optimization of inhibitors of hepatitis C virus NS3/4A protease.Org Lett. 2003 Nov 27;5(24):4631-4. doi: 10.1021/ol035827n. Org Lett. 2003. PMID: 14627401
-
Pyrrolidine-5,5-trans-lactams. 2. The use of X-ray crystal structure data in the optimization of P3 and P4 substituents.Org Lett. 2002 Dec 12;4(25):4479-82. doi: 10.1021/ol027014p. Org Lett. 2002. PMID: 12465917
-
Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection.Acc Chem Res. 2008 Jan;41(1):50-9. doi: 10.1021/ar700109k. Acc Chem Res. 2008. PMID: 18193821 Review.
-
Hepatitis C virus NS3-4A protease inhibitors: countering viral subversion in vitro and showing promise in the clinic.Curr Opin Drug Discov Devel. 2006 Sep;9(5):606-17. Curr Opin Drug Discov Devel. 2006. PMID: 17002221 Review.
Cited by
-
Development of cell-based assays for in vitro characterization of hepatitis C virus NS3/4A protease inhibitors.Antimicrob Agents Chemother. 2005 Apr;49(4):1381-90. doi: 10.1128/AAC.49.4.1381-1390.2005. Antimicrob Agents Chemother. 2005. PMID: 15793116 Free PMC article.
-
Systematic Studies on the Protocol and Criteria for Selecting a Covalent Docking Tool.Molecules. 2019 Jun 10;24(11):2183. doi: 10.3390/molecules24112183. Molecules. 2019. PMID: 31185706 Free PMC article.
-
Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of the hepatitis C virus.Genome Biol. 2008 Jan 23;9(1):R16. doi: 10.1186/gb-2008-9-1-r16. Genome Biol. 2008. PMID: 18215275 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources